RareCyte
Leaders across Research and Translational Medicine rely on RareCyte as the one-stop resource for Spatial Biology and Liquid Biopsy solutions. Our highly multiplexed fluorescent imaging systems, reagents, and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics through rare cell analysis.
Breaking Barriers in Spatial Proteomics with Single-Round Imaging
New discoveries HER2 detection: Novel method multimodal detection of HER2 from single tube of blood
Orion™ : The spatial solution for translational studies through clinical trials
Use of open-source software for quantitative analysis of multiplex images
Multimodal tissue imaging and machine learning to advance precision medicine
Spatial Biology: Applying Cellular Phenotyping in Health and Disease
Circulating Tumor Cells Circa 2022
Unlock Spatial Biology with Orion Technology: Explore the possibilities
Multiplexed Tissue Imaging using the Orion Platform to Reveal the Spatial Biology of Cancer
Comprehensive CTC analysis: Beyond enumeration to protein biomarkers and cancer cell genomes
Circulating Tumor Cell Analysis: Delivering on the Promise of Liquid Biopsy
Webinar - Patient Treatment Selection & Disease Monitoring by CTC enumeration
Webinar - Resolving the Complexity of Tissue Immune Response with Orion High-Dimensional Imaging
CytePicker® Module picking from slide
Tissue transcriptomics with CyteFinder® II Instruments
Working with the RarePlex® Developer Kit
RarePlex® Assays: Design and Analytical Validation
RarePlex® Panel and Developer Assays for CTC enumeration and characterization
RareCyte technology presentation at Harvard Medical School
CyteFinder and CytePicker (2:07)
AccuCyte Blood Separation (2:48)